This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
I note that the article by Dr. Irwin S. Budnick and associates, which originally appeared in the September, 1955, issue of the A. M. A. American Journal of Diseases of Children, has also appeared in excerpt form in The Journal, Jan. 21, 1956, page 209. I hasten to give our impressions following the use of reserpine in a much larger series of cases of pregnancy toxemia. A published series of 100 patients who have been treated at the Jefferson Davis Hospital (M. Rec. & Ann.49:363 [Aug.] 1955) reveals a neonatal death of one case in 96 delivered patients. In this same series there were three stillbirths. Our extended series, soon to be published, will include 300 such cases, with the same low fetal death rate. We attribute our excellent results mostly to the use of reserpine and hydralazine, and we find that in using these
Rogers SF. RESERPINE AND THE NEWBORN INFANT. JAMA. 1956;160(12):1090. doi:10.1001/jama.1956.02960470086021
Customize your JAMA Network experience by selecting one or more topics from the list below.